A new trial involving leuprolide was posted on August 28, 2026. The study, titled "A Phase Ia Trial Comparing the Pharmacokinetics/Pharmacodynamics, Safety, and Preliminary Efficacy of HHK001 and Enantone in Patients With Endometriosis," is registered under ClinicalTrials.gov identifier NCT07793162.
The trial is listed as Phase 1 and is currently not yet recruiting. It is designed to compare HHK001 with Enantone, a leuprolide-based product, in patients with endometriosis. According to the registry entry, the study will examine pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy between the two compounds.
No enrollment has started as of the listed date, and no outcomes, results, or safety findings have been reported at this stage. The trial's current status reflects only its registration and planned design, not any completed evaluation. Further updates would be expected once recruitment begins and data become available.
Readers interested in background on this compound can consult the leuprolide overview for additional context.